company background image
PANG logo

Pangaea Oncology BME:PANG Stock Report

Last Price

€1.77

Market Cap

€53.4m

7D

1.1%

1Y

-18.1%

Updated

23 Jul, 2024

Data

Company Financials +

PANG Stock Overview

A medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.

PANG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Pangaea Oncology, S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pangaea Oncology
Historical stock prices
Current Share Price€1.77
52 Week High€2.42
52 Week Low€1.68
Beta0.069
11 Month Change-2.21%
3 Month Change3.51%
1 Year Change-18.06%
33 Year Change15.69%
5 Year Change-7.81%
Change since IPO-37.46%

Recent News & Updates

Is Pangaea Oncology (BME:PANG) Weighed On By Its Debt Load?

Nov 09
Is Pangaea Oncology (BME:PANG) Weighed On By Its Debt Load?

Recent updates

Is Pangaea Oncology (BME:PANG) Weighed On By Its Debt Load?

Nov 09
Is Pangaea Oncology (BME:PANG) Weighed On By Its Debt Load?

Pangaea Oncology, S.A.'s (BME:PANG) About To Shift From Loss To Profit

May 17
Pangaea Oncology, S.A.'s (BME:PANG) About To Shift From Loss To Profit

Analysts Expect Pangaea Oncology, S.A. (BME:PANG) To Breakeven Soon

Feb 01
Analysts Expect Pangaea Oncology, S.A. (BME:PANG) To Breakeven Soon

Shareholder Returns

PANGES Life SciencesES Market
7D1.1%-3.8%0.04%
1Y-18.1%-17.6%14.3%

Return vs Industry: PANG matched the Spanish Life Sciences industry which returned -17.6% over the past year.

Return vs Market: PANG underperformed the Spanish Market which returned 14.3% over the past year.

Price Volatility

Is PANG's price volatile compared to industry and market?
PANG volatility
PANG Average Weekly Movement2.8%
Life Sciences Industry Average Movement6.6%
Market Average Movement3.0%
10% most volatile stocks in ES Market6.0%
10% least volatile stocks in ES Market0.7%

Stable Share Price: PANG has not had significant price volatility in the past 3 months.

Volatility Over Time: PANG's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006149Javier Rivela-Rodriguezwww.panoncology.com

Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies. It also provides biomarker discovery to identify novel targets for targeted therapies in pre-clinical development.

Pangaea Oncology, S.A. Fundamentals Summary

How do Pangaea Oncology's earnings and revenue compare to its market cap?
PANG fundamental statistics
Market cap€53.36m
Earnings (TTM)-€4.66m
Revenue (TTM)€9.95m

5.4x

P/S Ratio

-11.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PANG income statement (TTM)
Revenue€9.95m
Cost of Revenue€2.40m
Gross Profit€7.56m
Other Expenses€12.21m
Earnings-€4.66m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.15
Gross Margin75.92%
Net Profit Margin-46.78%
Debt/Equity Ratio18.0%

How did PANG perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.